Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDDecibel Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/11/2023 | Q2 2023 | $0.57 | -$0.73 | -1.3 | N/A | $0 |
| 05/15/2023 | Q1 2023 | $0.48 | -$0.53 | -1.01 | N/A | $0 |
| 03/14/2023 | Q4 2022 | $0.20 | -$0.64 | -0.84 | N/A | $0 |
| 11/09/2022 | Q3 2022 | $0.64 | -$0.64 | -1.28 | N/A | $0 |
| 08/10/2022 | Q2 2022 | $0.54 | -$0.68 | -1.22 | N/A | $0 |
| 05/12/2022 | Q1 2022 | $0.54 | -$0.56 | -1.1 | N/A | $0 |
| 03/18/2022 | Q4 2021 | $0.41 | -$0.52 | -0.93 | N/A | $0 |
| 11/10/2021 | Q3 2021 | $0.40 | -$0.66 | -1.06 | N/A | $0 |
| 08/10/2021 | Q2 2021 | $0.39 | -$0.47 | -0.86 | N/A | $0 |
| 05/13/2021 | Q1 2021 | $0.38 | -$0.90 | -1.28 | N/A | $0 |
| 03/29/2021 | Q4 2020 | N/A | -$0.56 | N/A | N/A | $0 |
| 09/29/2020 | Q3 2020 | N/A | -$0.97 | N/A | N/A | $0 |
| 06/29/2020 | Q2 2020 | N/A | -$1.06 | N/A | N/A | $0 |
| 03/30/2020 | Q1 2020 | N/A | -$1.57 | N/A | N/A | $0 |
| 12/30/2019 | Q4 2019 | N/A | -$0.85 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Decibel Therapeutics, Inc. Earnings: FAQ's
Decibel Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 6th, 2023 based offlast year's report dates.
In the previous quarter, Decibel Therapeutics, Inc. (:DBTX) reported $0.73 earnings per share (EPS) to beat the analysts' consensus estimate of $0.57 by $0.16.
The conference call for Decibel Therapeutics, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Decibel Therapeutics, Inc.'s latest earnings report can be read online.
Decibel Therapeutics, Inc. (:DBTX) has a recorded net income of $-63,005,000.Decibel Therapeutics, Inc. has generated $-2.52 earnings per share over the last four quarters.
Decibel Therapeutics, Inc. (:DBTX) has a price-to-earnings ratio of -1.95 and price/earnings-to-growth ratio is -0.02.